Epidemiology of Peripheral Artery Disease and Polyvascular Disease

Overview

Journal Circ Res

Specialty Cardiology & Vascular Diseases

Date 2021 Jun 10

PMID 34110907

Citations 164

Authors

Aaron W Aday

Kunihiro Matsushita

Affiliations

Soon will be listed here.

Abstract

Atherosclerotic lower extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects >230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are strongly linked to an increase risk of PAD. Although PAD has been historically underappreciated compared with coronary artery disease and stroke, greater attention on PAD in recent years has led to important new epidemiological insights in the areas of thrombosis, inflammation, dyslipidemia, and microvascular disease. In addition, the concept of polyvascular disease, or clinically evident atherosclerosis in multiple arterial beds, is increasingly identified as a particularly malignant cardiovascular disease worthy of special clinical attention and further study. It is noteworthy that PAD may increase the risk of adverse outcomes in similar or even greater magnitude than coronary disease or stroke. In this review, we highlight important new advances in the epidemiology of PAD with a particular focus on polyvascular disease, emerging biomarkers, and differential risk pathways for PAD compared with other atherosclerotic diseases.

Citing Articles

The BG Study Part 1 (Bergisch Gladbach): Development of a Prototype Coronary Artery Disease Risk Score Incorporating Peripheral Vascular Parameters-Preliminary Insights for Future CAD Risk Prediction Models in Vascular Patients.

Aras T, Tayeh M, Aswad A, Sharkawy M, Almuzakki Z, Dorweiler B J Clin Med. 2025; 14(4).

PMID: 40004827 PMC: 11856496. DOI: 10.3390/jcm14041297.

Comparisons of risk factors and outcomes between abdominal aortic aneurysm and peripheral arterial disease: a case-control study.

Beeton I, Acharya J, Kesin Meric B, Hobden J, Ali T, Han T Am J Med Open. 2025; 13:100087.

PMID: 39991140 PMC: 11847526. DOI: 10.1016/j.ajmo.2025.100087.

Neuromuscular Junction Damage in the Calf Muscles of Patients With Advanced Peripheral Artery Disease.

Tu H, Hakim A, Kim J, Zhu Z, Tian Y, Pipinos I Neuropathol Appl Neurobiol. 2025; 51(1):e70008.

PMID: 39989162 PMC: 11848508. DOI: 10.1111/nan.70008.

Transplantation of engineered endothelial progenitor cells with H19 overexpression promotes arterial reendothelialization and inhibits neointimal hyperplasia.

Ye Y, Huang L, Wang K, Sun Y, Zhou Z, Deng T J Tissue Eng. 2025; 16:20417314251315959.

PMID: 39974657 PMC: 11837068. DOI: 10.1177/20417314251315959.

Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications.

Mlynarska E, Czarnik W, Dzieza N, Jedraszak W, Majchrowicz G, Prusinowski F Int J Mol Sci. 2025; 26(3).

PMID: 39940862 PMC: 11817707. DOI: 10.3390/ijms26031094.

References

McDermott M, Greenland P, Liu K, Guralnik J, Criqui M, Dolan N . Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001; 286(13):1599-606. DOI: 10.1001/jama.286.13.1599. View

Anand S, Bosch J, Eikelboom J, Connolly S, Diaz R, Widimsky P . Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017; 391(10117):219-229. DOI: 10.1016/S0140-6736(17)32409-1. View

Fetterman J, Keith R, Palmisano J, McGlasson K, Weisbrod R, Majid S . Alterations in Vascular Function Associated With the Use of Combustible and Electronic Cigarettes. J Am Heart Assoc. 2020; 9(9):e014570. PMC: 7428567. DOI: 10.1161/JAHA.119.014570. View

Ouriel K, Zarins C . Doppler ankle pressure: an evaluation of three methods of expression. Arch Surg. 1982; 117(10):1297-1300. DOI: 10.1001/archsurg.1982.01380340031008. View

Hess C, Huang Z, Patel M, Baumgartner I, Berger J, Blomster J . Acute Limb Ischemia in Peripheral Artery Disease. Circulation. 2019; 140(7):556-565. DOI: 10.1161/CIRCULATIONAHA.119.039773. View

Meijer W, Grobbee D, Hunink M, Hofman A, Hoes A . Determinants of peripheral arterial disease in the elderly: the Rotterdam study. Arch Intern Med. 2000; 160(19):2934-8. DOI: 10.1001/archinte.160.19.2934. View

McDermott M, Fried L, Simonsick E, Ling S, Guralnik J . Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study. Circulation. 2000; 101(9):1007-12. DOI: 10.1161/01.cir.101.9.1007. View

Regensteiner J, Hiatt W, Coll J, Criqui M, Treat-Jacobson D, McDermott M . The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med. 2008; 13(1):15-24. DOI: 10.1177/1358863X07084911. View

Goodney P, Beck A, Nagle J, Welch H, Zwolak R . National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg. 2009; 50(1):54-60. DOI: 10.1016/j.jvs.2009.01.035. View

10.

Matsushita K, Sang Y, Ning H, Ballew S, Chow E, Grams M . Lifetime Risk of Lower-Extremity Peripheral Artery Disease Defined by Ankle-Brachial Index in the United States. J Am Heart Assoc. 2019; 8(18):e012177. PMC: 6818002. DOI: 10.1161/JAHA.119.012177. View

11.

Lu Y, Ballew S, Tanaka H, Szklo M, Heiss G, Coresh J . 2017 ACC/AHA blood pressure classification and incident peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study. Eur J Prev Cardiol. 2019; 27(1):51-59. PMC: 6938694. DOI: 10.1177/2047487319865378. View

12.

Panchenko E, Dobrovolsky A, Davletov K, Titaeva E, Kravets A, Podinovskaya J . D-dimer and fibrinolysis in patients with various degrees of atherosclerosis. Eur Heart J. 1995; 16(1):38-42. DOI: 10.1093/eurheartj/16.1.38. View

13.

Grundy S, Stone N, Bailey A, Beam C, Birtcher K, Blumenthal R . 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018; 139(25):e1082-e1143. PMC: 7403606. DOI: 10.1161/CIR.0000000000000625. View

14.

Aboyans V, Ricco J, Bartelink M, Bjorck M, Brodmann M, Cohnert T . 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric,.... Eur Heart J. 2017; 39(9):763-816. DOI: 10.1093/eurheartj/ehx095. View

15.

Dratva J, Probst-Hensch N, Schmidt-Trucksass A, Caviezel S, de Groot E, Bettschart R . Atherogenesis in youth--early consequence of adolescent smoking. Atherosclerosis. 2013; 230(2):304-9. DOI: 10.1016/j.atherosclerosis.2013.08.004. View

16.

Allison M, Cushman M, Solomon C, Aboyans V, McDermott M, Goff Jr D . Ethnicity and risk factors for change in the ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis. J Vasc Surg. 2009; 50(5):1049-56. PMC: 2783523. DOI: 10.1016/j.jvs.2009.05.061. View

17.

Menke A, Casagrande S, Geiss L, Cowie C . Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA. 2015; 314(10):1021-9. DOI: 10.1001/jama.2015.10029. View

18.

Selvin E, Erlinger T . Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004; 110(6):738-43. DOI: 10.1161/01.CIR.0000137913.26087.F0. View

19.

Murray G, Butcher I, Heald C, Lee R, Chambless L, Folsom A . Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008; 300(2):197-208. PMC: 2932628. DOI: 10.1001/jama.300.2.197. View

20.

Tzoulaki I, Murray G, Lee A, Rumley A, Lowe G, Fowkes F . Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study. Eur Heart J. 2007; 28(3):354-62. DOI: 10.1093/eurheartj/ehl441. View